CVE-2023-42666
CVE-2023-42666 is a medium-severity vulnerability in Dexma Dexgate with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-200.
Key facts
- Severity: Medium (CVSS 3.x base score 5.3)
- EPSS exploit prediction: 0% (30th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-200
- Affected product: Dexma Dexgate
- Published:
- Last modified:
Description
The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.
Frequently asked questions
- What is CVE-2023-42666?
- The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.
- How severe is CVE-2023-42666?
- CVE-2023-42666 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
- Is CVE-2023-42666 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-42666?
- CVE-2023-42666 affects Dexma Dexgate. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-42666?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-42666 published?
- CVE-2023-42666 was published on 2023-10-19 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*
More vulnerabilities in Dexma Dexgate
- CVE-2023-41089 — High (CVSS 8.0): The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to…
- CVE-2023-41088 — Medium (CVSS 6.3): The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow…
- CVE-2023-42435 — Medium (CVSS 5.5): The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to…
- CVE-2023-40153 — Medium (CVSS 5.4): The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the…
All CVEs affecting Dexma Dexgate →
Other CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities
- CVE-2026-27604 — Critical (CVSS 10.0): FOSSBilling is a free, open-source billing and client management system. Starting in version 0.5.4 and prior to version…
- CVE-2026-40965 — Critical (CVSS 10.0): Cloud Foundry UAA versions v76.12.0 through v78.12.0 are vulnerable to a private key exposure. The server contains a…
- CVE-2026-42826 — Critical (CVSS 10.0): Exposure of sensitive information to an unauthorized actor in Azure DevOps allows an unauthorized attacker to disclose…
- CVE-2025-29270 — Critical (CVSS 10.0): Incorrect access control in the realtime.cgi endpoint of Deep Sea Electronics devices DSE855 v1.1.0 to v1.1.26 allows…
- CVE-2025-61481 — Critical (CVSS 10.0): An issue in MikroTik RouterOS v.7.14.2 and SwOS v.2.18 exposes the WebFig management interface over cleartext HTTP by…
- CVE-2025-53624 — Critical (CVSS 10.0): The Docusaurus gists plugin adds a page to your Docusaurus instance, displaying all public gists of a GitHub user.…
Browse all CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities →